Semaglutide
A GLP-1 receptor agonist that reduces appetite and improves glucose control, widely…
The read
What people observed
Every report answers on a 1–5 scale. This is the whole distribution, never an average pretending to be one number, though the average is beside it.
1 · no effect
3
2 · barely
2
3 · modest
3
4 · clearly worked
6
5 · textbook
1
3.0/5
Average reported outcome
73%
Would run it again
15
Reports filed · directional
What it did, and what else showed up
Counts across this compound's reports, never an average. One report can select several answers.
Reported positive outcomes
more energy
4
skin / hair
4
cardiovascular / circulation
4
better sleep
3
mood / focus
3
fat loss
2
faster recovery
2
joint / tendon relief
2
appetite suppression
1
libido
1
strength / pump
1
cognition
1
injury healing
1
better bloodwork
1
Reported side effects
Kept separate from positive outcomes on purpose.
none / clean
5
GI / nausea
3
headache
3
heart rate
3
sleep disruption
2
mood / anxiety
2
injection-site irritation
1
appetite change
1
How it was run
What people brought it in for, and how long they stayed on it. Intent, not a result or a treatment claim.
What people were researching
sleep
1
mood / anxiety
1
libido / sexual function
1
body composition
1
immune / inflammation
1
How long they ran it
1 wk
4
2 wk
1
4 wk
4
6 wk
1
12 wk
3
16 wk+
2
Anecdote, never medical advice.
These are anonymous personal reports on an experimental research compound, not clinical evidence, and they never set the grade. Talk to a licensed clinician before you start, stop, or change a dose.